ARCHIVES

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Bypass Budget Calls For $5.98 Billion

December 6, 2002

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

January 28, 2005

In Brief: Knowledge Surgeons, Radiotherapists, Pathologists Untapped, Zubrod Suggests

February 20, 1976

ImClone Founding CEO Samuel Waksal Charged With Securities Fraud, Conspiracy, Perjury

June 14, 2002

NCI Director Among Bush Appointees Asked To Submit Resignation.

December 12, 2008

Proposed Regulations for Center Grants In Federal Register

October 29, 1976